A New Low-Cost and Accurate Diagnostic mHealth System for Patients with COVID-19 Pneumonia
Over the last two years, COVID-19 pneumonia has killed more than six million people worldwide. To self-triage pneumonia patients, many mobile Health (mHealth) solutions have been developed. Some of these solutions only provide guidelines and trace outbreaks. Others collect inaccurate vitals and/or a...
Saved in:
Published in | 2022 IEEE International Conference on Digital Health (ICDH) pp. 123 - 128 |
---|---|
Main Authors | , , , |
Format | Conference Proceeding |
Language | English |
Published |
IEEE
01.07.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Over the last two years, COVID-19 pneumonia has killed more than six million people worldwide. To self-triage pneumonia patients, many mobile Health (mHealth) solutions have been developed. Some of these solutions only provide guidelines and trace outbreaks. Others collect inaccurate vitals and/or are considered costly. To address these challenges, a cost-effective and accurate mHealth system was designed in this paper. The system consists of several biosensors (e.g., oxygen saturation) as they are considered significant for the disease assessment. In addition, a new mobile application was developed to collect biometric vitals and transmit them to a HIPPA compliant server. Our real-world experiments demonstrated that the new system was strongly correlated with the gold standard systems in terms of pulse rate and temperature (e.g., 90%). Moreover, the difference in the rate of change between the two systems for the measurements were mostly insignificant (e.g., p-\text{value} \approx 0.77 ). Lastly, the prototype cost is approximately 20 USD. |
---|---|
DOI: | 10.1109/ICDH55609.2022.00027 |